FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Ref: CC-LAP657Hu81-100 ul
100 ul
Información del producto
FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Información adicional
Size
100 ul
Applications
ICC
IF.
IHC
WB
IF.
IHC
WB
Concentration
500µg/mL
Research Area
Tumor immunity
Immunogen
-
Organism species
Homo sapiens (Human)
Alternative Names
Epithin
HAI
MT-SP1
Matriptase
Membrane-type serine protease 1
PRSS14
Prostamin
SNC19
Serine protease 14
TADG15
Tumor-associated differentially-expressed gene 15
HAI
MT-SP1
Matriptase
Membrane-type serine protease 1
PRSS14
Prostamin
SNC19
Serine protease 14
TADG15
Tumor-associated differentially-expressed gene 15
Item Name
Suppression Of Tumorigenicity 14
UniProt ID
AAH30532.1
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Usage
1:25-100
1:25-100
1:250-2500
Immunocytochemistry: 5-20µg/mL
Immunohistochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Western blotting: 0.2-2µg/mL
1:25-100
1:250-2500
Immunocytochemistry: 5-20µg/mL
Immunohistochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Western blotting: 0.2-2µg/mL